← SynDRA
TORCITABINE
SynDRA canonical compound SYN0019382 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DCK | TK2 |
|---|
| Mechanism of action | DNA polymerase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- DNA polymerase inhibitor
- HBV P INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Torcitabina
- NV-02C
- L-Deoxycytidine
- NV 02C
- 6BZN07BMW3
- torcitabinum
- RefChem:933198
- 2'-DEOXY-L-CYTIDINE
- L-dC
- MFCD02683609
- LdC
- Torcitabine [USAN]
- beta-L-2'-Deoxycytidine
- Torcitabine [USAN:INN]
- UNII-6BZN07BMW3
- 2'-eoxy--ytidine
- .beta.-L-2'dCyd
- TORCITABINE [INN]
- Torcitabine (USAN/INN)
- 2'-Deoxy-beta-L-cytidine
- L-2'-DEOXYCYTIDINE
- 1-(2-Deoxy-b-L-erythro-pentofuranosyl)cytosine
- .beta.-L-2'-Deoxycytidine
- SCHEMBL639556
- EBC-48110
- AKOS015854829
- ND05747
- HY-121513
- CS-0082252
- NS00120717
- C21554
- D06196
- F82332
- EN300-7391699
- BRD-K12451815-001-01-9
- 1-(2-Deoxypentofuranosyl)-4-imino-1,4-dihydropyrimidin-2-ol
- 2'-Deoxy-L-cytidine hydrochloride
- QQ2ABG4AB8
Look up TORCITABINE in the interactive SynDRA portal →